Associated Papers
Integrating evidence from protein domains to identify cancer driver mutations.
Ostroverkhova D et al.
Protein Science : a Publication of the Protein Society, 2026
Comprehensive Genomic Profiles of Melanoma in Veterans Compared to Reference Databases.
Mettman D et al.
Federal Practitioner : for the Health Care Professionals of the Va, Dod, and Phs, 2025
DIS3 Variants are Associated With Primary Ovarian Insufficiency: Importance of Transcription/Translation in Oogenesis.
Johnstone EB et al.
The Journal of Clinical Endocrinology and Metabolism, 2023
DIS3: The Enigmatic Gene in Multiple Myeloma.
Ohguchi Y et al.
International Journal of Molecular Sciences, 2023
Loss of ribonuclease DIS3 hampers genome integrity in myeloma by disrupting DNA:RNA hybrid metabolism.
Gritti I et al.
The Embo Journal, 2022
NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial.
Rosa-Rosa JM et al.
Cancers, 2022
Liquid Biopsy-Derived DNA Sources as Tools for Comprehensive Mutation Profiling in Multiple Myeloma: A Comparative Study.
Heestermans R et al.
Cancers, 2022
DIS3 mutations in multiple myeloma impact the transcriptional signature and clinical outcome.
Todoerti K et al.
Haematologica, 2022
Targeted genomic analysis of cutaneous T cell lymphomas identifies a subset with aggressive clinicopathological features.
Argyropoulos KV et al.
Blood Cancer Journal, 2020
Monosomic loss of MIR15A/MIR16-1 is a driver of multiple myeloma proliferation and disease progression.
Chesi M et al.
Blood Cancer Discovery, 2020
The RNA Exosome and Human Disease.
Fasken MB et al.
Methods in Molecular Biology (clifton, N.j.), 2020
Nuclear mRNA Surveillance Mechanisms: Function and Links to Human Disease.
Singh P et al.
Journal of Molecular Biology, 2018
Multiple Myeloma Genomics: A Systematic Review.
Weaver CJ et al.
Seminars in Oncology Nursing, 2017
A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias.
Lionetti M et al.
Oncotarget, 2015
The 3' to 5' Exoribonuclease DIS3: From Structure and Mechanisms to Biological Functions and Role in Human Disease.
Robinson SR et al.
Biomolecules, 2015
Whole-exome sequencing of primary plasma cell leukemia discloses heterogeneous mutational patterns.
Cifola I et al.
Oncotarget, 2015
Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M(3)P).
Kortüm KM et al.
Annals of Hematology, 2015
The molecular spectrum and clinical impact of DIS3 mutations in multiple myeloma.
Weißbach S et al.
British Journal of Haematology, 2015
Multiple myeloma-associated hDIS3 mutations cause perturbations in cellular RNA metabolism and suggest hDIS3 PIN domain as a potential drug target.
Tomecki R et al.
Nucleic Acids Research, 2014